K. Wah Group logo

K. Wah Group

Asia, Hong Kong Island, Hong Kong, Hong Kong

Description

K. Wah Group is engaged in property development and investment, entertainment and resorts, hospitality, and construction materials.

Investor Profile

K. Wah Group has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does K. Wah Group frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Loyal Valley Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Lake Bleu Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
AC
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Apricot Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CCB Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
BOCOM International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Shenzhen Capital Group
Asia, Hunan, China, Nanshan
Co-Investments: 1
Sino Biopharmaceutical
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 1
CI
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1

What are some of recent deals done by K. Wah Group?

Akeso Biopharma

Zhongshan, Anhui, China

Akeso Biopharma is a biopharmaceutical company committed to the discovery, development, and commercialization of therapies.

BiopharmaBiotechnologyHealth Care
Series DNov 4, 2019
Amount Raised: $150,000,000